Abstract
Background
Cervical cancer is a common malignant gynecological disease that threatens the health of women all over the world. The abnormal expression of Annexin A5 (ANXA5) is closely related to the biological behavior of various malignant tumors, however, the relationship between ANXA5 and cervical cancer is still unclear. Therefore, the effects of low expression of ANXA5 on the proliferation, apoptosis, migration and invasion of cervical cancer cells (HeLa) and its related mechanism were explored.
Methods
The cells were divided into three groups: ANXA5-si group, negative control group and blank group. RNA interference was used to suppress ANXA5 expression. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, colony formation assay, flow cytometry and propidium iodide (PI) staining, wound healing assay and transwell assay were employed to detect cell proliferation, apoptosis, migration and invasion respectively. Meanwhile, gene expression was detected by qPCR and Western blotting.
Results
ANXA5 suppression lead to the increase of proliferation, migration, invasion and the decrease of apoptosis of cervical cancer HeLa cells. Furthermore, the expression of both pPI3K and pAkt increased.
Conclusion
ANXA5 might inhibit Hela cells proliferation and metastasis by regulating PI3K/Akt signal pathway.
Similar content being viewed by others
Availability of data and material
Not applicable.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21660
van Genderen HO, Kenis H, Hofstra L, Narula J, Reutelingsperger CP (2008) Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783(6):953–963. https://doi.org/10.1016/j.bbamcr.2008.01.030
Shyu VB, Hsu CE, Wen CJ, Wun TC, Tang R, Achilefu S, Wei FC, Cheng HY (2017) Novel injury site targeted fusion protein comprising annexin v and kunitz inhibitor domains ameliorates ischemia-reperfusion injury and promotes survival of ischemic rat abdominal skin flaps. Ann Plast Surg 78(3 Suppl 2):S129–S134. https://doi.org/10.1097/SAP.0000000000001018
Bollinger AL, Bollinger T, Rupp J, Shima K, Gross N, Padayachy L, Chicheportiche R, Puga Yung GL, Seebach JD (2020) Annexin V expression on CD4(+) T cells with regulatory function. Immunology 159(2):205–220. https://doi.org/10.1111/imm.13140
Yang J, Liu P, Ma D, Zhao P, Zhang Y, Lu Y, Li Y, Huang Y, Chen Y, Wang J (2021) Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia. Pediatr Hematol Oncol 38(1):36–48. https://doi.org/10.1080/08880018.2020.1810182
Peng B, Guo C, Guan H, Liu S, Sun MZ (2014) Annexin A5 as a potential marker in tumors. Clin Chim Acta 427:42–48. https://doi.org/10.1016/j.cca.2013.09.048
Ding XM, Li JX, Wang K, Wu ZS, Yao AH, Jiao CY, Qian JJ, Bai DS, Li XC (2017) Effects of silencing annexin A5 on proliferation and invasion of human cholangiocarcinoma cell line. Eur Rev Med Pharmacol Sci 21(7):1477–1488
Tang J, Qin Z, Han P, Wang W, Yang C, Xu Z, Li R, Liu B, Qin C, Wang Z, Tang M, Zhang W (2017) High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma. Int J Oncol 50(5):1839–1847. https://doi.org/10.3892/ijo.2017.3942
Baek HS, Park N, Kwon YJ, Ye DJ, Chun YJJO (2017) Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ–nuclear factor-κB signaling pathway in prostate cancer cells. Oncotarget 8(43):74263–74275. https://doi.org/10.18632/oncotarget.19392
Sun X, Liu S, Wang J, Wei B, Guo C, Chen C, Sun MZ (2018) Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways. Cell Death Dis 9(6):637. https://doi.org/10.1038/s41419-018-0685-8
Li X, Ma W, Wang X, Ci Y, Zhao Y (2018) Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells. Cancer Biomark 23(1):23–32. https://doi.org/10.3233/CBM-171040
Ediriweera MK, Tennekoon KH, Samarakoon SR (2019) Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol 59:147–160. https://doi.org/10.1016/j.semcancer.2019.05.012
Zhou J, Chang M, Li J, Fang T, Hu J, Bai C (2018) Knockdown of annexin A5 restores gefitinib sensitivity by promoting G2/M cell cycle arrest. Respir Res 19(1):96. https://doi.org/10.1186/s12931-018-0804-1
Hassan HA, Salem ML, Gouida MS, El-Azab KM (2018) Comparative expression of caspases and annexin V in benign and malignant ovarian tumors. J Cancer Res Ther 14(5):1042–1048. https://doi.org/10.4103/0973-1482.187282
Sun CB, Zhao AY, Ji S, Han XQ, Sun ZC, Wang MC, Zheng FC (2017) Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance. World J Gastroenterol 23(39):7168–7173. https://doi.org/10.3748/wjg.v23.i39.7168
Jeong JJ, Park N, Kwon YJ, Ye DJ, Moon A, Chun YJ (2014) Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis. J Biol Chem 289(4):2469–2481. https://doi.org/10.1074/jbc.M113.450163
Peng B, Liu S, Guo C, Sun X, Sun MZJFO (2016) ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell. Future Oncol 12(1):31–42
Wu L, Yang L, Xiong Y, Guo H, Shen X, Cheng Z, Zhang Y, Gao Z, Zhu X (2014) Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells. Tumour Biol 35(12):12327–12337. https://doi.org/10.1007/s13277-014-2545-1
Wang J, Zhang Y, Liu X, Ma J, Zhang GJOR (2014) Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling. Oncol Rep 32(6):2557
Zhang X, Huo L, Jin H, Han Y, Wang J, Zhang Y, Lai X, Le Z, Zhang J, Hua Z (2017) Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis. Oncotarget 8(26):42602–42612. https://doi.org/10.18632/oncotarget.16645
Funding
The present study was supported by the Key Subjects in University of Hebei Province (Grant no. 2013-4) and by the Education Department of Hebei Province (Grant no. Z2014026).
Author information
Authors and Affiliations
Contributions
XW: experiments operation; YD: data collection, data analysis, manuscript writing; JZ: data collection, manuscript writing; XL: project development, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Code availability
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, X., Dai, Y., Zhang, J. et al. Annexin A5 suppression promotes the progression of cervical cancer. Arch Gynecol Obstet 307, 937–943 (2023). https://doi.org/10.1007/s00404-022-06524-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06524-1